1. Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?

   • Roy O. Mathew
   • Elvira O. Gosmanova
   • Mandeep S. Sidhu

   EDITORIAL 19 June 2018 Pages: 241 - 243

2. Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway

   • Angshuman Maulik
   • Sean M. Davidson
   • Derek M. Yellon

   ORIGINAL ARTICLE Open access 15 May 2018 Pages: 245 - 253

   

3. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)

   • Marian Goicoechea
   • Soledad García de Vinuesa
   • José Luño

   ORIGINAL ARTICLE 08 June 2018 Pages: 255 - 263

   

4. A 10-Year Trend in Statin Use Among Older Adults in Australia: an Analysis Using National Pharmacy Claims Data

   • Richard Ofori-Asenso
   • Jenni Ilomäki
   • Danny Liew

   ORIGINAL ARTICLE 23 May 2018 Pages: 265 - 272

   

5. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions

   • Susan H. Boklage
   • Elisabetta Malangone-Monaco
   • Joseph Elassal

   ORIGINAL ARTICLE Open access 31 May 2018 Pages: 273 - 280

   

6. Target Population of Non-deferrable Surgery and Uncontrolled Severe Bleeding Related to Dabigatran

   • Silvia Calabria
   • Emanuele Forcesi
   • Nello Martini

   SHORT COMMUNICATION 04 June 2018 Pages: 281 - 286

7. Ticagrelor Versus Clopidogrel as Part of Dual or Triple Antithrombotic Therapy: a Systematic Review and Meta-Analysis

   • Ioannis Andreou
   • Alexandros Briasoulis
   • Dimitrios Alexopoulos

   ORIGINAL ARTICLE 15 May 2018 Pages: 287 - 294

   

8. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial

   • Xianliang Wang
   • Zhiqiang Zhao
   • Boli Zhang

   ORIGINAL ARTICLE 30 April 2018 Pages: 295 - 300

   

9. Systematic Review of Methods Used for the Microvascular Assessment of Peripheral Arterial Disease

   • Qinzhong Chen
   • Robert S. Rosenson

   REVIEW ARTICLE 29 May 2018 Pages: 301 - 310

10. Effect of Anagliptin and Sitagliptin in Type 2 Diabetic Patients with Dyslipidemia and Cardiovascular Risk: What Is the Real REASON Behind It?

    • Venu Gopal Jonnalagadda
    • Harish Prabhanna Char
    • Praveen Kumar Ankana

    LETTER TO THE EDITOR 07 March 2018 Pages: 311 - 311